Revelation Biosciences Warrant
REVBW
14 hedge funds and large institutions have $31.6K invested in Revelation Biosciences Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
15,717% more capital inflows, than outflows
Capital inflows: $4.74K | Capital outflows: $30
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
17% more funds holding
Funds holding: 12 → 14 (+2)
4.29% less ownership
Funds ownership: 35.4% → 31.11% (-4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pine Valley Investments
Marlton,
New Jersey
|
+$3.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.29K |
| 3 |
Cowen and Company
New York
|
+$30 |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29 |
| 5 |
Clear Street
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wolverine Asset Management
Chicago,
Illinois
|
-$30 |
REVBW Hedge Fund Activity: Q3 2023 in Review
14 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2023, worth a combined $31.6K — up 5.5% from $30K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new REVBW positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Pine Valley Investments, adding an estimated $3.4K. The largest seller was Wolverine Asset Management, cutting an estimated $30.
- 14 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2023, up from 12 in Q2 2023.
- Funds reported $31.6K of Revelation Biosciences Warrant stock for Q3 2023, up 5.5% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences Warrant positions in Q3 2023 and 0 closed out, a net change of +2 holders.
- The largest Revelation Biosciences Warrant buyer in Q3 2023 was Pine Valley Investments, an estimated $3.4K added.
- The largest Revelation Biosciences Warrant seller in Q3 2023 was Wolverine Asset Management, an estimated $30 sold.
Based on aggregated 13F filings for Q3 2023.